Pag\u0101ju\u0161aj\u0101 gad\u0101 Grindeks turpin\u0101ja izaugsmi tirgus dal\u012bbniekiem gaid\u012btaj\u0101 l\u012bmen\u012b. Grindeks koncerna t\u012br\u0101 pe\u013c\u0146a p\u0113rn sasniegusi 7,2 miljonus latu, par 8,8 % p\u0101rsniedzot iepriek\u0161\u0113j\u0101 gada pe\u013c\u0146as r\u0101d\u012bt\u0101ju. Koncerna apgroz\u012bjums bijis 51,5 miljoni latu, kas ir par 9,3 miljoniem latu jeb par 22 % vair\u0101k nek\u0101 2006. gad\u0101.<\/p>\n\n\n\n
Izmai\u0146as neprognoz\u0113<\/strong><\/p>\n\n\n\n K\u0101 skaidrots Grindeks p\u0101rskat\u0101, b\u016btisk\u0101ko pe\u013c\u0146as pieaugumu devusi gatavo z\u0101\u013cu p\u0101rdo\u0161anas apjomu palielin\u0101\u0161an\u0101s par 22 %. Kopum\u0101 gatav\u0101s z\u0101les p\u0101rdotas par 47,7 miljoniem latu, kas ir par 8,7 miljoniem latu vair\u0101k nek\u0101 iepriek\u0161. Visvair\u0101k medikamentu realiz\u0113ts galvenajos eksporta tirgos \u2013 Krievij\u0101 un NVS valst\u012bs, kopum\u0101 par 41,7 miljoniem latu. 73 % no kop\u0113j\u0101 gatavo z\u0101\u013cu p\u0101rdo\u0161anas apjoma veidoja ori\u0123in\u0101lprodukta Mildron\u0101ts<\/em> p\u0101rdo\u0161ana, sasniedzot 34,8 miljonu latu apgroz\u012bjumu, kas ir par 6,2 miljoniem latu vai 22 % vair\u0101k nek\u0101 2006. gad\u0101.<\/p>\n\n\n\n Pozit\u012bvi Grindeks pe\u013c\u0146as r\u0101d\u012bt\u0101jus ietekm\u0113jis ar\u012b akt\u012bvo farmaceitisko vielu eksporta pieaugums, sasniedzot 3,8 miljonus latu, kas ir par 22 % vair\u0101k nek\u0101 2006. gad\u0101. Koncerna sara\u017eot\u0101 produkcija eksport\u0113ta uz 44 pasaules valst\u012bm, kopum\u0101 par 48,8 miljoniem latu, kas ir par 8,9 miljoniem latu vai 22 % vair\u0101k nek\u0101 iepriek\u0161.<\/p>\n\n\n\n Koncerns turpina realiz\u0113t invest\u012bciju programmu, un kop\u0113jais Grindeks invest\u012bciju apjoms p\u0113rn ir 8,7 miljoni latu, kas ir par 1,2 miljoniem latu jeb 16 % vair\u0101k nek\u0101 iepriek\u0161.<\/p>\n\n\n\n Grindeks finan\u0161u r\u0101d\u012bt\u0101ji nek\u0101dus p\u0101rsteigumus nesag\u0101d\u0101ja un sakrita ar tirgus un anal\u012bti\u0137u gaid\u0101m, saka Parex Asset Management vec\u0101kais akciju anal\u012bti\u0137is J\u0101nis Pra\u0146\u0113vi\u010ds. K\u0101 prognoz\u0113ts, m\u0101rketinga aktivit\u0101\u0161u, izp\u0113tes darb\u012bbas un lielo invest\u012bciju rezult\u0101t\u0101 pe\u013c\u0146as pieaugums p\u0113rn bija pietic\u012bgs. Ta\u010du k\u0101 pozit\u012bv\u0101s iez\u012bmes var min\u0113t atkar\u012bbas mazin\u0101\u0161anos no Krievijas tirgus \u2013 2007. gad\u0101 Krievijas da\u013ca bija 51,3 % no neto ie\u0146\u0113mumiem, kas ir nedaudz maz\u0101k k\u0101 53,5 % 2006. gad\u0101.<\/p>\n\n\n\n T\u0101pat komp\u0101nija pl\u0101no turpin\u0101t darbu pie jaunu noieta tirgu iekaro\u0161anas \u2013 \u0161ogad Turcij\u0101 tiks piere\u0123istr\u0113ti tr\u012bs medikamenti, turpin\u0101sies ar\u012b darbs pie Mildron\u0101ta<\/em> re\u0123istr\u0101cijas \u0136\u012bn\u0101, kas var\u0113tu \u0161o atkar\u012bbu v\u0113l vair\u0101k samazin\u0101t. Ta\u010du, t\u0101 k\u0101 finan\u0161u r\u0101d\u012bt\u0101ji sakrita ar gaid\u012btajiem, zi\u0146as neatst\u0101ja nek\u0101du iespaidu uz komp\u0101nijas akciju cenu, kas sasniedza 6,01 latu un, visticam\u0101k, ar\u012b tuv\u0101kaj\u0101s dien\u0101s \u0161aj\u0101 jom\u0101 b\u016btiskas izmai\u0146as eksperts neparedz.<\/p>\n\n\n\n P\u0113rn komp\u0101nijas tirgoto akciju skaits veidoja 1,988 miljonus, sasniedzot apgroz\u012bjumu 15,42 miljonu latu apm\u0113r\u0101, kas bijis otrs liel\u0101kais apgroz\u012bjums bir\u017e\u0101. Pra\u0146\u0113vi\u010ds sac\u012bja, ka lielais apgroz\u012bjums skaidrojams ar to, ka pietiekami daudz akciju \u2013 43,3 % no kop\u0113j\u0101 skaita atrodas br\u012bv\u0101 apgroz\u012bb\u0101. T\u0101d\u0113j\u0101di komp\u0101nijai ir viens no augst\u0101kajiem br\u012bv\u0101 apgroz\u012bb\u0101 eso\u0161o akciju \u012bpatsvars, kas nepieder strat\u0113\u0123iskajiem akcion\u0101riem Latvijas akciju tirg\u016b. Turkl\u0101t \u0161o br\u012bv\u0101 apgroz\u012bb\u0101 eso\u0161o akciju kapitaliz\u0101cija sasniedz 25 miljonus latu, kas ir pietiekami daudz, lai komp\u0101nija b\u016btu pievilc\u012bga invest\u012bciju fondiem. T\u0101 akciju skaits br\u012bvaj\u0101 apgroz\u012bb\u0101 un kapitaliz\u0101cija nav r\u0101d\u012bt\u0101ji, kas main\u0101s ik p\u0101rdienas, ar\u012b \u0161ogad Grindeks atrad\u012bsies l\u012bdz\u012bg\u0101 situ\u0101cij\u0101 un b\u016bs starp trim likv\u012bd\u0101kaj\u0101m RFB akcij\u0101m, prognoz\u0113 eksperts.<\/p>\n\n\n\n Ar\u012b SEB Unibankas brokeru noda\u013cas vad\u012bt\u0101ja Nat\u0101lija To\u010delovska skaidro, ka uz\u0146\u0113muma akcijas tirdzniec\u012bbai nav spekulat\u012bvs raksturs, l\u012bdz ar to b\u016bs gr\u016bti sagaid\u012bt strauju akciju kust\u012bbu un, visticam\u0101k, ar\u012b tuv\u0101kaj\u0101s dien\u0101s \u0161aj\u0101 jom\u0101 b\u016btiskas izmai\u0146as neredz\u0113sim.<\/p>\n\n\n\n Autors:<\/strong> \u017danete H\u0101ka<\/p>\n","protected":false},"excerpt":{"rendered":" Pag\u0101ju\u0161aj\u0101 gad\u0101 Grindeks turpin\u0101ja izaugsmi tirgus dal\u012bbniekiem gaid\u012btaj\u0101 l\u012bmen\u012b. Grindeks koncerna t\u012br\u0101 pe\u013c\u0146a p\u0113rn sasniegusi 7,2 miljonus latu, par 8,8 % p\u0101rsniedzot iepriek\u0161\u0113j\u0101 gada pe\u013c\u0146as…<\/p>\n","protected":false},"author":3,"featured_media":6601,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-538","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-jaunums"],"acf":[],"_links":{"self":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/538","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/comments?post=538"}],"version-history":[{"count":0,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/538\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media\/6601"}],"wp:attachment":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media?parent=538"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/categories?post=538"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/tags?post=538"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}